KPTI
Karyopharm Therapeutics Inc
Price:  
9.00 
USD
Volume:  
200,245.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

KPTI Stock Forecast & Price Target

KPTI Stock Price Forecast

The average stock forecast for Karyopharm Therapeutics Inc (KPTI) in the next 12 months is 13.67 USD. This price target corresponds to an upside of 50.03%. The range of stock forecasts for KPTI is 7.07 - 16.80 USD. Based on the ratings of 13 analysts, the consensus recommendation for KPTI is BUY.
Target Low Average Median High
Price (USD) 7.07 13.67 15.30 16.80
Upside -22.39% 50.03% 67.95% 84.41%

Recommendation Trends

The latest consensus rating for KPTI is "BUY". This is the average recommendation of 13 analysts: 0 strong sell, 0 sell, 2 hold, 7 buy, 4 strong buy. In the previous period, 13 analysts also majorly recommmended "BUY" for KPTI.

KPTI Financial Stock Forecast

Revenue This Year
136.46M
-6.58%
from 146.07M
Revenue Next Year
158.41M
16.09%
from 136.46M
EPS This Year
-4.36
-49.62%
from -8.65
EPS Next Year
-3.52
-19.23%
from -4.36